Middle Coast Investing had a solid Q3, powered by four buyouts of portfolio companies and strong performance from several stocks. Read the full letter here.

This week, RWE withdrew from a $10 billion Namibia green hydrogen project, the latest example of companies considering such ...

Dyne Therapeutics' FORCE platform targets rare diseases with promise, but high valuation and trial risks limit upside. Find out why DYN stock is a sell.

Applied Materials said it expects a $710 million hit to its revenue from new restrictions on its China exports, pressuring shares of the chip manufacturing equipment maker Friday.

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more.